DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Ruff CT, Giugliano RP, Antman EM et al.
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
Am Heart J 2010;
160: 635-641
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.